Marcus Buschbeck and Lab
@MarcusBuschbeck
Group leader at Josep Carreras Institute For updates on the lab and the wider scientific community follow us on Bsky. #chromatin #leukaemia
SEE YOU SOON! We are slowly migrating our posting activity. For latest news find us here: @marcusbuschbeck.bsky.social Or visit our website at buschbecklab.org

OPPORTUNITY for a CHEMIST to JOIN US Are you interested in: 👍 Computer-aided design 👍 Organic synthesis 👍 Biomedicine 👍 Drug development 👍 A multidisciplinary team 👍 And a PhD in Barcelona 🌐 Then check this out! rb.gy/nc3lf3

Last opportunity to join our network on nuclear metabolism as PhD student.
🚨 2nd Recruitment call is now open! 🚨 ⚠️There are still 3 Doctoral Candidate positions available in NUCLEAR! If you're ready to dive into innovative research in metabolic regulation of genome, join our international program. 📩Apply now: nuclear-dn.eu/recruitment/
It is a great honor and greater responsibility to take over the chair of the @EHA_Hematology research committee from Brian Huntly and @DelwelRuud. Together with Dominique Bonnet I will lead the committee dealing with all aspects of research at @EHA_Hematology.

From Barcelona to Milan ✈️ Proud of our IJC delegation attending #EHA2025! 👏 @EHA_Hematology
MEET THE TEAM. René Winkler and Marcus Buschbeck will attend @EHA_Hematology 2025 congress in Milan. Find us at: JUN 12 - Mol Hemato workshop, Brown 3 JUN 13 - EHA-ISEH Joint Symposium, Amber 7 JUN 14 - YoungEHA, Brown Hall 2 + Poster 1606 JUN 15 - Myeloid Neoplasia, Brown 1

Please RT! Great opportunity for managers. Help taking our research institute to the next level. Previous experience in managing a public institute in Spain is a major plus.
We're hiring 🚀 🔎 We're seeking for a MANAGING DIRECTOR 👩💼 👉 careers.carrerasresearch.org/jobs/5915609-v… Join a leading institute in research against blood cancers to lead its administrative and financial organization. ✅ Our Institute is a Severo Ochoa Centre of Excellence @SOMM_alliance,…
Thank you, Lorena, for great discussions. It was a pleasure to meet the labs forming @CRESCO_SFF_UiO center.
We were privileged to host @MarcusBuschbeck from @CarrerasIJC as @CRESCO_SFF_UiO Guest Speaker. Full "auditorium" to listen to his inspiring work, from mechanistic insights into #AML vulnerabilities to clinical trials. Thank you for your visit Marcus & cheers! 😊
Only two weeks left to catch this postdoc opportunity at our institute. 25 group leaders are available as hosts?
😱Aspiring researchers, do not miss this #postdoc opportunity in #bloodcancers at @CarrerasIJC ! Explore our available hosts to find your supervisor and secure your place in this 3-year transformative journey! Apply by June 1👉carrerasleaders.eu @MSCActions #researchjobs
😱Aspiring researchers, do not miss this #postdoc opportunity in #bloodcancers at @CarrerasIJC ! Explore our available hosts to find your supervisor and secure your place in this 3-year transformative journey! Apply by June 1👉carrerasleaders.eu @MSCActions #researchjobs
Highly recommended postdoc opportunity! As a plus you get us as neighbors!
🚨 Unique #Postdoc opportunity via @CarrerasLeaders! Join our team and lead cutting-edge research in #leukemia & #epigenetics. We're seeking passionate scientists eager to make an impact in leukemia research @CarrerasIJC. 📩 Contact me to apply— and please RT! 🔁
NOW or NEVER! Last opportunity to join the @CarrerasIJC through this exceptional, fully funded @MSCActions postdoc program!
📢Call 4 is OPEN! Join the CarrerasLeaders program at @CarrerasIJC for a 3-year postdoc. 📅 Apply by June 1, 2025 ✨World-class researchers supervision ✨International secondments ✨Top-tier research infrastructures More details at carrerasleaders.eu @MSCActions
White smoke in the Badalone coastal mountains! Ari Melnick will join us as our next Director. Welcome on board of the @CarrerasIJC ship, Ari!
We are pleased to announce that Dr Ari Melnick has been appointed new Director of the Josep Carreras Leukaemia Research Institute. Dr Melnick will lead IJC in our mission to advance #research in #leukaemia and other malignant blood diseases. Read the full release here:…
We are pleased to announce that Dr Ari Melnick has been appointed new Director of the Josep Carreras Leukaemia Research Institute. Dr Melnick will lead IJC in our mission to advance #research in #leukaemia and other malignant blood diseases. Read the full release here:…
Today our fellows had an informal breakfast meeting with @MarcusBuschbeck, the Scientific Coordinator. Inspired by the beautiful nature around @CarrerasIJC, our fellows blend their passion for #bloodcancers research with a love for hiking and the outdoors—next meetup, outside?
NEW LAB MEMBER! We welcome Francesco B. Ciriscioli as Master student to the team. > More info now here: bsky.app/profile/marcus…
Thanks a lot to @Leaves_Eyes for a fantastic and entertaining concert. You made my day!

HURRY UP! ONLY 3 DAYS LEFT! To apply for a PhD position in our lab @carrerasIJC in Badalona-Barcelona Projects at the intersection of metabolism and chromatin Starting -/+ September 2025 Being part of a @MSCActions network. Apply here: nuclear-dn.eu

Join us for this exciting hybrid seminar by Sylvia Erhardt who found an unexpected function of BET inhibitors by studying chromatin regulation. See you Friday March 14 at 12pm CET!
Join our next #InvitedLecture: 🗨️"Locus-specific protein profiling identifies the bromodomain inhibitor JQ1 as a molecular glue targeting centromeres" 🗣️ Sylvia Erhardt 🗓️ Friday, 14 March at 11:30 CET 📍 IJC Auditorium + Online Register here 👉us06web.zoom.us/webinar/regist…
Join our next #InvitedLecture: 🗨️"Locus-specific protein profiling identifies the bromodomain inhibitor JQ1 as a molecular glue targeting centromeres" 🗣️ Sylvia Erhardt 🗓️ Friday, 14 March at 11:30 CET 📍 IJC Auditorium + Online Register here 👉us06web.zoom.us/webinar/regist…
FAREWELL! Thanks a lot to Rachil Komproglou for having managed the @MSCActions ITN @intercept_mds. Having submitted the last deliverable, she is now starting her own company providing molecular services to plant breeders. Farewell, Rachil, and all the best for your new goal!
